AMBI on NASDAQ

Ambit Biosciences

Ambit was an American pharmaceutical company focused on development of kinase inhibitor therapeutics to treat a variety of human diseases. As of March 2014, the company was based in San Diego, California, and consisted of a single facility.3 From Wikipedia, CC BY-SA 4.0

Price unavailable

Last updated Oct 16, 2026.

Overview

Jan 1, 2000Founded1

Compare with another stock.

  • TickerAMBI on NASDAQ1
  • Industrypharmaceutical industry1
  • HeadquartersSan Diego1
  • Websitewww.ambitbio.com
  • Incorporated inDE4
  • Business address11080 Roselle Street, San Diego, Ca 921214
  • Filer categorySmaller reporting company4

See how the biggest companies compare on our leaderboards

Ambit was an American pharmaceutical company focused on development of kinase inhibitor therapeutics to treat a variety of human diseases. As of March 2014, the company was based in San Diego, California, and consisted of a single facility. Ambit made an initial public offering in May 2013, and was listed on the NASDAQ exchange under the symbol "AMBI". Ambit was acquired by Daiichi Sankyo in 2014 and is no longer traded on the NASDAQ exchange.3

Former names

  • AVENTA BIOSCIENCES CORPJun 12, 2002 to Jun 12, 20024

Timeline

  1. May 2013Went public Listed on NASDAQ1
  2. Jan 1, 2000Founded Founded1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4